Different volumes of the M-TAPA nerve block for pain after sleeve gastrectomy
Official title: Perioperative Analgesic Effect of Different Volumes of Modified Thoracoabdominal Perichondrial Approach on Patients Undergoing Sleeve Gastrectomy: Prospective Randomized Trial
Run by Menoufia University · NCT07510347 · Data updated 2026-11-12
This trial tests whether giving different amounts of local anesthetic with the M-TAPA nerve block reduces pain and opioid use after laparoscopic sleeve gastrectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Menoufia University Academic / other |
| Locations | 1 site (Shibīn al Kawm, Menofia) |
| Status | Recruiting |
| Started | May 18, 2025 |
| Main results expected | May 18, 2026 |
| Study ends | May 18, 2026 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT07510347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20–60 years scheduled for elective laparoscopic sleeve gastrectomy with ASA class I–II and no recent chronic opioid use are ideal candidates.
✕Probably not a fit
Patients with ASA >2, chronic opioid use, prior major abdominal surgery, coagulopathy, local infection, allergy to local anesthetics, or significant neuromuscular or psychiatric disorders are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center prospective randomized trial will enroll 60 adults scheduled for elective laparoscopic sleeve gastrectomy and randomize them to receive bilateral ultrasound-guided modified thoracoabdominal perichondrial approach (M-TAPA) blocks with three different volumes of 0.25% bupivacaine (20, 30, or 40 mL per side). Blocks are performed after induction of standardized general anesthesia and all patients receive standard intraoperative monitoring and postoperative care. Primary outcomes include postoperative pain scores and opioid consumption, with safety and recovery metrics tracked as secondary outcomes. Patients with ASA >2, chronic opioid use, prior major abdominal surgery, coagulopathy, local infection, or relevant neurologic or psychiatric disorders are excluded.
Why it matters
Potential benefit: If successful, the optimized M-TAPA volume could lower postoperative pain and reduce opioid requirements, supporting faster recovery after sleeve gastrectomy.
How similar studies have gone: Regional abdominal blocks such as TAP blocks and early reports of M-TAPA have shown opioid-sparing and improved pain control after abdominal surgery, but randomized data specific to sleeve gastrectomy and optimal M-TAPA volumes remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Patients will be eligible for the study if they meet the following criteria: 1. Adults aged \> 20 years to 60 years. 2. Scheduled for elective laparoscopic sleeve gastrectomy. Exclusion Criteria Patients will be excluded from the study if any of the following conditions apply: 1. American Society of Anesthesiology (ASA) ASA \> class 2. 2. History of chronic pain or opioid use for more than 3 months before surgery. 3. Previous major abdominal surgery (which may affect M-TAPA efficacy). 4. Known hypersensitivity or allergy to local anesthetics (e.g., bupivacaine). 5. Coagulopathy or ongoing anticoagulant therapy that could increase bleeding risk. 6. Local infection at the injection site. 7. Neuromuscular disorders affecting pain perception. 8. Patient with mental or psychiatric disorders.
Where it's running
-
Menofia faculty of medicine
Shibīn al Kawm, Menofia, Egypt Recruiting
Study contacts
- Principal investigator: Ahmed Mohamed elkhouly, bachelor — Menoufia University
- Study coordinator: Ahmed Mohamed Elkhouly, bachelor's degree
- Email: xahmed035@gmail.com
- Phone: +201017829302
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Timing of a single dexmedetomidine dose before laryngoscopy and intubation and its effect on stress response.
This trial will test whether giving one dose of dexmedetomidine earlier or closer to surgery can reduce the blood pressure and heart rate changes caused by laryngoscopy and intubation in adults aged 18–65 with ASA I–II.
-
Early Time-Restricted Eating in Adults With Mild Asthma and Those Without Asthma
Researchers will see if eating all meals within a set early window affects health and quality of life in adults with mild asthma compared with adults without asthma.
-
HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults
This project will test whether 4 weeks of high-intensity interval training or time-restricted eating improves heart and metabolic health in adolescents and young adults with overweight or obesity.
-
Lifestyle for Brain Health — Time-Restricted Eating and Mindfulness
This 9-month program tests whether combining yoga-based mindfulness with time-restricted eating improves cognition, physical fitness, metabolism, and plasma tau levels in adults 60–80 with subjective or mild cognitive impairment and positive pTau217.
-
Optimizing meal timing to improve health in night shift workers
This study tests if changing when night shift workers eat can help them lose weight and improve their overall health.
-
Time-restricted eating for people with type 2 diabetes and microalbuminuria
This study tests whether following an 8–10 hour daily eating window can improve kidney health in adults with type 2 diabetes and microalbuminuria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.